T. Walenzyk et al. / Tetrahedron 61 (2005) 7366–7377
7371
3 mmol) was dissolved in the butylamine (658 mg, 9 mmol)
allowed to stir at 50 8C for 10 min. The solvent was
evaporated leaving a yellow solid. Glacial acetic acid (5 ml)
was added and allowed to stir at 70 8C for 10 min. The
mixture was added to ice water and a white precipitate
formed which was filtered, washed with water and dried.
The white solid was recrystallised from ethyl acetate to
yield white needles (630 mg, 2.6 mmol, 86%).
for 10 min. The solvent was evaporated giving a light
yellow solid. Glacial acetic acid (10 ml) was added and
allowed to stir at 70 8C for 10 min. The mixture was added
to ice water and extracted with ethyl acetate. The organic
layer was dried over Na2SO4 and evaporated to give a
yellow solid. The solid was recrystallised from ethyl acetate
to yield white needles (2.30 g, 6.4 mmol, 71%).
Mp 108 8C; IR (KBr): n~ (cmK1)Z3319, 2959, 2932, 2850,
1982, 1642, 1522, 1387, 753; UV/vis (MeOH): lmax (nm)
(log 3)Z203 (4.37), 236 (4.29), 305 (3.83); 1H NMR
(300 MHz, DMSO): d (ppm)Z0.83 (t, JZ6.7 Hz, 3H,
CH3), 1.16–1.33 (m, 18H, 9!CH2), 1.48–1.60 (m, 2H,
CH2), 3.28 (m, 2H, CH2), 6.81 (s, 1H, H-3), 7.53 (ddd, JZ
1.0, 7.2, 8.0 Hz, 1H, H-6), 7.73 (dd, JZ0.6, 8.5 Hz, 1H,
H-8), 7.89 (ddd, JZ1.7, 7.2, 8.5 Hz, 1H, H-7), 8.05 (dd, JZ
1.7, 8.0 Hz, 1H, H-5), 9.12 (t, JZ5.8 Hz, 1H, N–H); 13C
NMR (75 MHz, DMSO): d (ppm)Z13.8 (C, CH3), 22.0 (K,
CH2), 26.3 (K, CH2), 28.6 (K, CH2), 28.7 (K, CH2), 28.8
(K, CH2), 28.9 (K, CH2), 28.9 (K, CH2), 28.9 (K, CH2),
31.2 (K, CH2), 39.2 (K, CH2), 39.4 (K, CH2), 110.2 (C,
C-3), 118.7 (C, C-8), 123.5 (Cquat, C-9), 124.8 (C, C-5),
125.9 (C, C-6), 134.9 (C, C-7), 155.0 (Cquat, C-2), 155.7
(Cquat, C-10), 158.7 (Cquat, C]O), 177.2 (Cquat, C-4); MS
(CI-MS, NH3) m/z (%): 375.2 (100) [MCNH3]C, 358.2
(56) [MH]C. Elemental analysis: C22H31NO3 Calcd: C
73.92; H 8.74; N, 3.92. Found: C, 73.75; H, 8.75; N, 3.74.
Mp 130 8C; IR (KBr): n~ (cmK1)Z3319, 3079, 2954, 2868,
1685, 1642, 1387, 755; UV/vis (MeOH): lmax (nm)
(log 3)Z202 (4.37), 236 (4.29), 305 (3.85); 1H NMR
(300 MHz, DMSO): d (ppm)Z0.91 (t, JZ7.2 Hz, 3H,
CH3), 1.34 (qd, JZ7.2, 14.1 Hz, 2H, CH2), 1.54 (XX, JZ
7.2 Hz, 2H, CH2), 3.30 (q, JZ7.2 Hz, 2H, CH2), 6.82 (s, 1H,
H-3), 7.53 (ddd, JZ1.0, 7.1, 8.0 Hz, 1H, H-6), 7.73 (dd, JZ
1.0, 8.5 Hz, 1H, H-8), 7.89 (ddd, JZ1.7, 7.1, 8.5 Hz, 1H,
H-7), 8.05 (dd, JZ1.7, 8.0 Hz, 1H, H-5), 9.10 (t, JZ5.6 Hz,
1H, N–H); 13C NMR (75 MHz, DMSO): d (ppm)Z13.6 (C,
CH3), 19.5 (K, CH2), 30.8 (K, CH2), 38.8 (K, CH2), 110.2
(K, C-3), 118.7 (C, C-8), 123.5 (Cquat, C-9), 124.8 (C,
C-5), 125.9 (C, C 6), 134.9 (C, C-7), 155.0 (Cquat, C-2),
155.7 (Cquat, C-10), 158.7 (Cquat, C]O), 177.2 (Cquat, C-4);
MS (CI-MS, NH3) m/z (%): 263.1 (100) [MCNH3]C, 246.1
(26) [MH]C. Elemental analysis: C14H15NO3 Calcd: C,
68.56; H, 6.16; N, 5.71. Found: C, 68.58; H, 6.04; N, 5.61.
4.6.3. 4-Oxo-4H-chromene-2-carboxylic acid octylamide
(3b). Ethyl-4-oxo-4H-chromene-2-carboxylate (655 mg,
3 mmol) and octylamine (1163 mg, 9 mmol) were dissolved
in dichloromethane (5 ml) and allowed to reflux for 10 min.
The solvent was evaporated leaving a light yellow solid.
Glacial acetic acid (5 ml) was added and allowed to stir at
70 8C for 10 min. The mixture was added to ice water and
extracted with ethyl acetate. The organic layer was dried
over Na2SO4 and evaporated to give a white solid. The solid
was recrystallised from ethyl acetate to yield white needles
(826 mg, 2.7 mmol, 91%).
4.6.5. 4-Oxo-4H-chromene-2-carboxylic acid (3-dimethyl-
amino-propyl)-amide (4). Ethyl-4-oxo-4H-chromene-2-
carboxylate (655 mg, 3 mmol) and 3-dimethylamino-propyl-
amine (920 mg, 9 mmol) were dissolved in dichloromethane
(5 ml) and allowed to reflux for 20 min. The solvent was
evaporated, glacial acetic acid (5 ml) was added and the
solution allowed to stir at 70 8C for 10 min. The mixture was
added to ice water and extracted with ethyl acetate. The
organic layer was dried over Na2SO4 and evaporated to give
a yellow solid. The solid was recrystallised from ethyl
acetate to yield white needles (691 mg, 2.5 mmol, 84%).
Mp 131 8C; IR (KBr): n~ (cmK1)Z3314, 2927, 2849, 1684,
1646, 1529, 1392, 751; UV/vis (MeOH): lmax (nm)
(log 3)Z202 (4.36), 236 (4.29), 305 (3.84); 1H NMR
(300 MHz, CDCl3): d (ppm)Z0.85–0.91 (m, 3H, CH3),
1.24–1.46 (m, 10H, 5!CH2), 1.61–1.72 (m, 2H, CH2), 3.49
(tq, JZ6.2, 7.2 Hz, 2H, CH2), 6.91 (s, 1H, N–H), 7.16 (s,
1H, H-3), 7.45 (ddd, JZ1.0, 7.2, 8.1 Hz, 1H, H-6), 7.52 (dd,
JZ0.5, 8.5 Hz, 1H, H-8), 7.73 (ddd, JZ1.7, 7.2, 8.5 Hz, 1H,
H-7), 8.22 (dd, JZ1.7, 8.0 Hz, 1H, H-5); 13C NMR
(75 MHz, CDCl3): d (ppm)Z14.1 (C, CH3), 22.6 (K,
CH2), 26.7 (K, CH2), 27.0 (K, CH2), 29.1 (K, CH2), 29.2
(K, CH2), 29.5 (K, CH2), 31.8 (K, CH2), 40.1 (K, CH2),
112.1 (C, C-3), 118.0 (C, C-8), 124.4 (Cquat, C-9), 126.0
Mp 125 8C; IR (KBr): n~ (cmK1)Z3289, 2976, 2946, 2805,
1686, 1640, 1534, 1460, 1392, 759; UV/vis (MeOH): lmax
(nm) (log 3)Z203 (4.37), 236 (4.29), 305 (3.84); H NMR
1
(300 MHz, DMSO): d (ppm)Z1.69 (p, JZ6.9 Hz, 2H, CH2),
2.15 (s, 6H, 2!CH3), 2.28 (t, JZ6.9 Hz, 2H, CH2), 3.33
(dd, JZ7.2, 12.7 Hz, 2H, CH2), 6.82 (s, 1H, H-3), 7.53 (ddd,
JZ1.0, 7.2, 8.0 Hz, 1H, H-6), 7.71 (dd, JZ0.7, 8.5 Hz, 1H,
H-8), 7.89 (ddd, JZ1.7, 7.2, 8.5 Hz, 1H, H-7), 8.05 (dd, JZ
1.7, 8.0 Hz, 1H, H-5), 9.25 (t, JZ5.5 Hz, 1H, N–H); 13C
NMR (75 MHz, DMSO): d (ppm)Z26.4 (K, CH2), 38.0 (K,
CH2), 45.1 (C, 2!CH3), 56.9 (K, CH2), 110.2 (C, C-3),
118.6 (C, C-8), 123.5 (Cquat, C-9), 124.9 (C, C-5), 125.9
(C, C-5), 126.2 (C, C-6), 134.5 (C, C-7), 154.8 (Cquat
C-2), 155.3 (Cquat, C-10), 159.2 (Cquat, C]O), 178.2 (Cquat
,
,
(C, C-6), 134.9 (C, C-7), 155.0 (Cquat, C-2), 155.6 (Cquat,
C-10), 158.7 (Cquat, C]O), 177.2 (Cquat, C-4); MS (PI-
EIMS) m/z (%): 58.1 (100) [Me2N]CH2]C, 274.1 (11)
[M]C%. Elemental analysis: C15H18N2O3 Calcd: C, 65.68;
H, 6.61; N, 10.21. Found: C, 65.63; H, 6.41; N, 10.08.
C-4); MS (CI-MS, NH3) m/z (%): 319.1 (100) [MCNH3]C,
302.1 (40) [MH]C. Elemental analysis: C18H23NO3 Calcd:
C, 71.73; H, 7.69; N, 4.65. Found: C, 71.62; H, 7.58; N,
4.43.
4.6.6. Trimethyl-{3-[(4-oxo-4H-chromene-2-carbonyl)-
amino]-propyl}-ammonium iodide (5). Iodomethane
(260 mg, 1.83 mmol) was dissolved in chloroform (5 ml)
and added to a solution of 4-oxo-4H-chromene-2-carboxylic
acid (3-dimethylamino-propyl)-amide (500 mg, 1.82 mmol)
4.6.4. 4-Oxo-4H-chromene-2-carboxylic acid dodecyla-
mide (3c). Ethyl-4-oxo-4H-chromene-2-carboxylate
(1.96 g, 9 mmol) and dodecylamine (5.0 g, 27 mmol) were
dissolved in dichloromethane (10 ml) and allowed to reflux